对转移性乳腺癌 (MBC) 的可持续诊断方法的评估
Andrea Masperi1, Cristiano Michele Girlando2, Valerio Cubadda2
1Division of Radiology, IEO European Institute of Oncology IRCCS, Via Giuseppe Ripamonti 435, 20141, Milan, Italy. andrea.masperi@ieo.it.
La Radiologia medica
|September 3, 2025
概括
全身MRI对于转移性乳腺癌患者来说更安全,但对环境的影响很大. 如果重复扫描是有限的,FDG-PET/CT更可持续,平衡患者安全和环保成像.
科学领域:
- 放射学
- 癌症学
- 环境科学
背景情况:
- 在转移性乳腺癌 (MBC) 中评估骨转移是复杂的.
- 越来越多的能源消耗和排放问题需要节能成像解决方案.
- 评估诊断成像的环境和生物成本对于MBC治疗的监测至关重要.
研究的目的:
- 为了比较三种诊断成像方法来监测MBC治疗.
- 评估和比较每个成像途径的环境影响 (能源使用,温室气体排放).
- 评估与每个途径相关的生物成本 (辐射暴露,对比介质量).
主要方法:
- 对70名骨主导型MBC患者的回顾性分析.
- 全身MRI (WB-MRI),FDG-PET/CT和骨扫描 (BS) 与CT-CAP的比较
- 量化扫描时间,能源消耗,温室气体排放量 (kgCO2e),辐射剂量和对比介质使用情况.
主要成果:
- 而WB-MRI的能源消耗和温室气体排放量最高.
- FDG-PET/CT显示了适度的能量使用和排放,随着反复扫描而增加.
- 使用CT-CAP的BS对环境的影响最小,但辐射和对比剂量较高.
结论:
- 虽然WB-MRI对MBC治疗的监测具有更高的生物安全性,但它对环境有很大的影响.
- 当重复扫描被最小化时,FDG-PET/CT提供了一个更可持续的选择.
- 未来的战略应整合成像途径,并优先考虑环保诊断的低能耗技术.
相关概念视频
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


